278 related articles for article (PubMed ID: 30537446)
1. The Antifibrotic Activity of Prostacyclin Receptor Agonism Is Mediated through Inhibition of YAP/TAZ.
Zmajkovicova K; Menyhart K; Bauer Y; Studer R; Renault B; Schnoebelen M; Bolinger M; Nayler O; Gatfield J
Am J Respir Cell Mol Biol; 2019 May; 60(5):578-591. PubMed ID: 30537446
[TBL] [Abstract][Full Text] [Related]
2. TBK1 regulates YAP/TAZ and fibrogenic fibroblast activation.
Aravamudhan A; Haak AJ; Choi KM; Meridew JA; Caporarello N; Jones DL; Tan Q; Ligresti G; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2020 May; 318(5):L852-L863. PubMed ID: 32159970
[TBL] [Abstract][Full Text] [Related]
3. Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis.
Liu F; Lagares D; Choi KM; Stopfer L; Marinković A; Vrbanac V; Probst CK; Hiemer SE; Sisson TH; Horowitz JC; Rosas IO; Fredenburgh LE; Feghali-Bostwick C; Varelas X; Tager AM; Tschumperlin DJ
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L344-57. PubMed ID: 25502501
[TBL] [Abstract][Full Text] [Related]
4. Andrographolide ameliorates bleomycin-induced pulmonary fibrosis by suppressing cell proliferation and myofibroblast differentiation of fibroblasts via the TGF-β1-mediated Smad-dependent and -independent pathways.
Li J; Feng M; Sun R; Li Z; Hu L; Peng G; Xu X; Wang W; Cui F; Yue W; He J; Liu J
Toxicol Lett; 2020 Mar; 321():103-113. PubMed ID: 31706003
[TBL] [Abstract][Full Text] [Related]
5. Sirtuin 6 inhibits myofibroblast differentiation via inactivating transforming growth factor-β1/Smad2 and nuclear factor-κB signaling pathways in human fetal lung fibroblasts.
Zhang Q; Tu W; Tian K; Han L; Wang Q; Chen P; Zhou X
J Cell Biochem; 2019 Jan; 120(1):93-104. PubMed ID: 30230565
[TBL] [Abstract][Full Text] [Related]
6. Dopamine Receptor D1 Is Exempt from Transforming Growth Factor
Gao AY; Diaz Espinosa AM; Nguyen BBN; Link PA; Meridew J; Jones DL; Gibbard DF; Tschumperlin DJ; Haak AJ
J Pharmacol Exp Ther; 2023 Sep; 386(3):277-287. PubMed ID: 37024146
[TBL] [Abstract][Full Text] [Related]
7. Novel differences in gene expression and functional capabilities of myofibroblast populations in idiopathic pulmonary fibrosis.
Walsh SM; Worrell JC; Fabre A; Hinz B; Kane R; Keane MP
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L697-L710. PubMed ID: 30091381
[TBL] [Abstract][Full Text] [Related]
8. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
[TBL] [Abstract][Full Text] [Related]
9. Yap/Taz Deletion in Gli
Liang M; Yu M; Xia R; Song K; Wang J; Luo J; Chen G; Cheng J
J Am Soc Nephrol; 2017 Nov; 28(11):3278-3290. PubMed ID: 28768710
[TBL] [Abstract][Full Text] [Related]
10. Cartilage oligomeric matrix protein in idiopathic pulmonary fibrosis.
Vuga LJ; Milosevic J; Pandit K; Ben-Yehudah A; Chu Y; Richards T; Sciurba J; Myerburg M; Zhang Y; Parwani AV; Gibson KF; Kaminski N
PLoS One; 2013; 8(12):e83120. PubMed ID: 24376648
[TBL] [Abstract][Full Text] [Related]
11. Lung myofibroblasts are characterized by down-regulated cyclooxygenase-2 and its main metabolite, prostaglandin E2.
Gabasa M; Royo D; Molina-Molina M; Roca-Ferrer J; Pujols L; Picado C; Xaubet A; Pereda J
PLoS One; 2013; 8(6):e65445. PubMed ID: 23755232
[TBL] [Abstract][Full Text] [Related]
12. Human antigen R promotes lung fibroblast differentiation to myofibroblasts and increases extracellular matrix production.
Al-Habeeb F; Aloufi N; Traboulsi H; Liu X; Nair P; Haston C; Azuelos I; Huang SK; White ES; Gallouzi IE; Di Marco S; Eidelman DH; Baglole CJ
J Cell Physiol; 2021 Oct; 236(10):6836-6851. PubMed ID: 33855709
[TBL] [Abstract][Full Text] [Related]
13. Selective YAP/TAZ inhibition in fibroblasts via dopamine receptor D1 agonism reverses fibrosis.
Haak AJ; Kostallari E; Sicard D; Ligresti G; Choi KM; Caporarello N; Jones DL; Tan Q; Meridew J; Diaz Espinosa AM; Aravamudhan A; Maiers JL; Britt RD; Roden AC; Pabelick CM; Prakash YS; Nouraie SM; Li X; Zhang Y; Kass DJ; Lagares D; Tager AM; Varelas X; Shah VH; Tschumperlin DJ
Sci Transl Med; 2019 Oct; 11(516):. PubMed ID: 31666402
[TBL] [Abstract][Full Text] [Related]
14. GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGFβ1.
Zmajkovicova K; Bauer Y; Menyhart K; Schnoebelen M; Freti D; Boucher M; Renault B; Studer R; Birker-Robaczewska M; Klenk A; Nayler O; Gatfield J
PLoS One; 2020; 15(2):e0228195. PubMed ID: 32053631
[TBL] [Abstract][Full Text] [Related]
15. Deglycosylated Azithromycin Attenuates Bleomycin-Induced Pulmonary Fibrosis via the TGF-β1 Signaling Pathway.
Ruan H; Gao S; Li S; Luan J; Jiang Q; Li X; Yin H; Zhou H; Yang C
Molecules; 2021 May; 26(9):. PubMed ID: 34068694
[TBL] [Abstract][Full Text] [Related]
16. Hippo signaling impairs alveolar epithelial regeneration in pulmonary fibrosis.
Warren R; Lyu H; Klinkhammer K; De Langhe SP
Elife; 2023 May; 12():. PubMed ID: 37166104
[TBL] [Abstract][Full Text] [Related]
17. Rac-GTPase promotes fibrotic TGF-β1 signaling and chronic kidney disease
Patel S; Tang J; Overstreet JM; Anorga S; Lian F; Arnouk A; Goldschmeding R; Higgins PJ; Samarakoon R
FASEB J; 2019 Sep; 33(9):9797-9810. PubMed ID: 31095421
[TBL] [Abstract][Full Text] [Related]
18. Myofibroblast YAP/TAZ activation is a key step in organ fibrogenesis.
He X; Tolosa MF; Zhang T; Goru SK; Ulloa Severino L; Misra PS; McEvoy CM; Caldwell L; Szeto SG; Gao F; Chen X; Atin C; Ki V; Vukosa N; Hu C; Zhang J; Yip C; Krizova A; Wrana JL; Yuen DA
JCI Insight; 2022 Feb; 7(4):. PubMed ID: 35191398
[TBL] [Abstract][Full Text] [Related]
19. YAP/TAZ regulates TGF-β/Smad3 signaling by induction of Smad7 via AP-1 in human skin dermal fibroblasts.
Qin Z; Xia W; Fisher GJ; Voorhees JJ; Quan T
Cell Commun Signal; 2018 Apr; 16(1):18. PubMed ID: 29695252
[TBL] [Abstract][Full Text] [Related]
20. STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF.
Pechkovsky DV; Prêle CM; Wong J; Hogaboam CM; McAnulty RJ; Laurent GJ; Zhang SS; Selman M; Mutsaers SE; Knight DA
Am J Pathol; 2012 Apr; 180(4):1398-412. PubMed ID: 22322297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
